To include your compound in the COVID-19 Resource Center, submit it here.

EC approves Vifor's Veltassa for hyperkalemia

Vifor Pharma Ltd. (SIX:VIFN) said the European Commission approved an MAA for Veltassa patiromer (RLY5016)

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE